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Self-rated health and functional capacity in
individuals reporting overlapping
symptoms of gastroesophageal reflux
disease, functional dyspepsia and irritable
bowel syndrome - a population based
study
Dorte Ejg Jarbøl* , Sanne Rasmussen, Kirubakaran Balasubramaniam, Sandra Elnegaard and Peter Fentz Haastrup
Abstract
Background: Gastroesophageal reflux disease (GERD), functional dyspepsia (FD) and irritable bowel syndrome (IBS)
are common functional gastrointestinal conditions with a significant impact on daily life. The objectives were to
analyse general self-rated health and self-reported functional capacity in adults meeting the criteria for GERD, FD
and IBS, respectively, and in individuals who meet the criteria for more than one of the conditions.
Methods: A nationwide study of 100,000 individuals aged 20 years and above, randomly selected in the general
Danish population. A web-based questionnaire survey formed the basis of this study. Questions regarding FD and
IBS were extracted from the ROME III adult questionnaire. Questions regarding GERD were developed based on the
Montreal definition. Self-rated health and functional capacity was measured by single global questions.
Results: Respondents meeting the criteria for either GERD, FD or IBS have significantly higher odds of reporting
poor self-rated health and impaired functional capacity compared to individuals not experiencing these functional
gastrointestinal conditions. Furthermore, respondents with overlapping gastrointestinal (GI) symptom complexes
have significantly higher odds of reporting poor self-rated health and impaired functional capacity compared to
respondents with symptoms compatible with only one of the symptom complexes.
Conclusions: This study demonstrates that individuals experiencing symptoms of GERD, FD or IBS report poor
self-rated health as well as impaired functional capacity. The impact on self-rated health and functional capacity is
highest among individuals experiencing overlapping symptoms of GERD, FD and IBS.
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Background
Global consensus has been established, and research has
operationalised gastrointestinal (GI) symptoms into
symptom complexes of gastroesophageal reflux disease
(GERD), functional dyspepsia (FD) and irritable bowel
syndrome (IBS) [1, 2].
The prevalence of GI symptoms is high in the gene-
ral population; in a recent study, we found that 20% of
the adult Danish population has experienced symp-
toms of either GERD, FD or IBS within a 4 week
period [3]. Furthermore, a significant overlap was seen
between the GI symptom complexes, meaning that a
substantial number of patients with either GERD, FD
or IBS met the criteria for one or both of the other
conditions [3].
Previous studies have shown that individuals suffering
from either GERD, FD or IBS have a substantially lower
quality of life [4–6]. These findings emphasise the im-
portance of the patient’s own assessment. However, the
patient’s subjective side of the matter comprises other
dimensions than quality of life that could be relevant
when assessing the impact of GI symptoms. It has been
demonstrated that self-rated health and quality of life
are distinct constructs that should be differentiated [7];
when evaluating quality of life, patients give much
greater emphasis to mental health than to physical func-
tioning, whereas the opposite is the case for self-rated
health [8].
Knowledge of how GI symptom complexes and the
overlap of multiple GI symptoms affect the individuals
in other dimensions than quality of life is sparse. It has
been demonstrated that overlapping GI symptoms affect
the evaluation of bodily pain and general health [6].
However, it has not been examined whether functional
capacity is impaired in individuals meeting the criteria
for more than one of the GI symptom complexes. It is
plausible that experiencing numerous symptoms affects
both the individual’s self-perceived health and functional
capacity negatively, but on the other hand, one could as-
sume that it is the quality of symptoms rather than the
quantity of symptoms that influences self-rated health
and functional capacity.
Taking the patient’s own assessments into consider-
ation is important not only as a sign of interest and em-
pathy from the clinician; it can also be important to
guide consultations to important questions, and to de-
termine which efforts should be made to handle the
symptoms [9].
Therefore, the aim of this study was to analyse general
self-rated health and self-reported functional capacity in
adults from the general population who met the cri-
teria for GERD, FD and IBS, respectively, and in indi-
viduals who met the criteria for more than one of the
conditions.
Methods
The study population
The study was designed as a nationwide cohort study of
100 000 people randomly selected from the general
population. All Danish citizens are registered in the
Danish Civil Registration System (CRS) with a unique
personal identification number. From the CRS, 100 000
adults aged 20 years or above were randomly selected
and invited to participate in a survey concerning a broad
range of symptom experiences. The individuals received
a postal letter explaining the purpose of the study. In the
letter, a unique 12-digit login for a secure webpage was
included. This provided access to a comprehensive web-
based questionnaire. In order to prevent the exclusion of
people with no internet access, the participants were
offered the opportunity that the survey could be con-
ducted as a telephone interview. The data collected from
the questionnaire form the basis of this study.
The questionnaire
The questionnaire was designed as a comprehensive
questionnaire exploring a broad range of symptom expe-
riences, including gastrointestinal symptoms. Questions
regarding GI symptoms were formed using internation-
ally validated scales. The questions regarding FD and
IBS were extracted from the ROME III Adult Question-
naire (RIIIAQ), which is validated by the ROME founda-
tion [2]. The RIIIAQ was translated into Danish according
to standardised methods [10]. The questions regarding
GERD were developed by an expert panel, comprising re-
searchers in the gastroenterological field, on the basis of
the Montreal definition and with inspiration from a prior
Danish study [1, 11]. The questionnaire was evaluated re-
garding comprehensibility, relevance, acceptability and
feasibility, and pilot tested before use. Further details on
the design of the study and data collection are described
in details elsewhere [12]. See also Additional file 1 includ-
ing the questionnaire developed for use in this study.
Defining GERD, FD and IBS
Based on the Montreal definition stating that GERD is
defined as a ‘condition that develops when the reflux of
the stomach contents causes troublesome symptoms and/
or complications’, we chose to operationalise the defin-
ition of GERD with the criteria listed in Table 1. The
first criterion includes individuals who have troublesome
symptoms based on frequency and severity of reflux
symptoms as suggested by the Montreal definition [1],
while the second criterion includes individuals who have
less frequent symptoms, but who might still find these
symptoms troublesome due to an aggravating factor,
specified in this study as impaired sleep or impaired
daily activities. The latter criterion was included due to a
study showing that it is too simplistic to define GERD
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on the basis of frequency and severity alone [11]. We
defined FD and IBS according to the ROME III criteria.
Table 1 shows how the diagnosis of FD and IBS has been
operationalised by the ROME foundation using the
ROME III Questionnaires (RIIIAQ). The ROME III
criteria for FD state that, in order to be diagnosed as
having FD, there must be no proof of structural diseases
likely to explain the symptoms [2]. In the present study
population we do unfortunately not have information
about whether they did undergo upper endoscopy. A
Danish study reported normal endoscopy in 59% of the
patients referred with dyspeptic symptoms, and a study
from a Brazilian outpatient clinic found 66% of the pa-
tients to have functional dyspepsia [13, 14]. We there-
fore chose to maintain the term functional dyspepsia
since this is the most likely diagnosis in an unselected
population experiencing dyspepsia. However, we cannot
exclude the possibility of individuals in this study having
an organic lesion at endoscopy.
Self-rated health and functional capacity
The questionnaire comprised a single global item con-
cerning general self-rated health extracted from the
Short Form 36 questionnaire [15]. The question asked
the participants to rate their overall health status with
the wording: ‘In general, would you say your health is:’.
The answering categories were: ‘Excellent’, ‘Very good’,
‘Good’, ‘Fair’ and ‘Poor’. Furthermore, functional capacity
was measured by the single global question: ‘Do you
feel well enough to do what you feel like doing?’. The
answering categories were: ‘Yes, mostly’, ‘Yes, some-
times’, ‘No, almost never’ and ‘I don’t know’. The ques-
tions were used in former national population-based
studies [16, 17].
Data analyses
The respondents were divided into two age groups of
20–49 and ≥ 50 years of age. The scale of self-rated
health was dichotomised into ‘good’ and ‘poor’ self-rated
health. Good self-rated health comprised the answers
‘Excellent’, ‘Very good’ and ‘Good’, whereas the answers
‘Fair’ and ‘Poor’ were categorised as ‘Poor’. The scale of
functional capacity was dichotomised into ‘unimpaired’
and ‘impaired’ functional capacity. Unimpaired func-
tional capacity comprised the answers ‘Yes, mostly’ and
‘Yes, sometimes’. The answer ‘No, almost never’ was
defined as impaired functional capacity. For individuals
answering ‘I don’t know’, we were unable to classify their
functional capacity, and their answer was categorised as
missing. Chi-square tests were used to test for differences
between gender and age groups, respectively.
Logistic regression models were used to test for inter-
action between gender and age groups for self-rated
health and functional capacity because we hypothesised
that self-rated health and functional capacity would be
reported differently among men and women under and
over 50 years of age. The distribution of proportions in
categories of self-rated health and functional capacity
was calculated for individuals meeting the criteria for
GERD, FD, IBS, respectively, and the overlap between
criteria.
Logistic regression analyses were used to calculate
odds ratios (ORs) with 95% confidence intervals (CIs)
for the associations between poor self-rated health, im-
paired functional capacity and GERD, FD and IBS and
the overlap of these, respectively. A subgroup analysis
for individuals meeting at least one of the criteria for the
GI symptom complexes was carried out. Due to correl-
ation between self-rated health and functional capacity,
the analyses were carried out separately for the two out-
comes. The ORs were calculated separately for men and
women in the two age groups due to interaction. Data
analyses were conducted using StataIC 13©.
Results
Of the 100, 000 randomly selected subjects, 4474 (4.7%)
were not eligible because they had either died, could not
Table 1 Operationalising the diagnosis of Gastroesophageal
reflux disease (GERD), Functional dyspepsia (FD), and Irritable
bowel syndrome (IBS) in terms used in the survey
GERD
A condition that develops when reflux of the stomach contents causes
troublesome symptoms and/or complications. Must include at least
one of the two criteria:
• Mild symptoms occurring more than 1 day a week or moderate to
severe symptoms at least once a week.
• Impaired sleep at least to some extent, or impaired daily activities at
least to a lesser extent and mild symptoms occurring at least once
a week, or moderate to severe symptoms at least 2–3 times
a month.
FD
Must include one or more of the following:
• Uncomfortably full after a regular-sized meal more than 1 day/week
in the last 3 months. Onset more than 6 months ago.
• Unable to finish a regular-sized meal more than 1 day/week in the
last 3 months. Onset more than 6 months ago.
• Pain or burning in the middle of the abdomen at least 1 day/week
in the last 3 months. Onset more than 6 months ago.
IBS
Must include:
Pain or discomfort in the abdomen at least 2 to 3 days/month in the
last 3 months with onset at least 6 months ago. For women, the pain
must not occur only during menstrual bleeding. And at least 2 of the 3
following criteria:
• Pain or discomfort gets better after bowel movements at least
sometimes.
• Onset of pain or discomfort associated with more frequent stools at
least sometimes or onset of pain, or discomfort associated with
fewer stools at least sometimes.
• Onset of pain or discomfort associated with loose stools at least
sometimes, or onset of pain or discomfort associated with hard
stools at least sometimes.
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be reached due to unknown address, were suffering from
severe illnesses (including dementia), had language prob-
lems or had moved abroad. Of the 95 253 (95.3%) eli-
gible subjects, 49 706 completed the questionnaire,
yielding an overall response rate of 52.2% (Fig. 1). The
median age of the respondents was 52 years Interquartile
range (IQR) (40–64) compared to 50 years IQR (36–63)
for non-respondents. Slightly more respondents were
women (53.2%) compared to non-respondents (48.6%).
The study group of interest for this paper is a subgroup
of 47 090 respondents completing all the questions re-
garding GERD, FD and IBS, respectively. More women
were represented in the age groups 20–49 years and
above 50 years, respectively (p < 0.001), and significant
more respondents were in the age group above 50 years
among both gender (p < 0.001).
A total of 770 (1.6%) of the respondents met the cri-
teria for all three symptom complexes, Table 2. The dis-
tribution of self-rated health and functional capacity of
respondents meeting 1) none of the criteria for the GI
symptom complexes, 2) the criteria only for GERD, FD
and IBS, respectively, and 3) the overlaps GERD + IBS,
FD + IBS, GERD + FD and GERD + FD + IBS, respectively,
appear from Table 2. All GI-complexes occurred more
frequently among females.
The results of the regression analyses are shown separ-
ately for men and women under and over 50 years of
age due to interaction between self-rated health/func-
tional capacity and sex and age. Respondents with any of
the GI symptom complexes had significantly higher odds
of reporting poor self-rated health and impaired func-
tional capacity compared to respondents with no GI
symptoms, Table 3.
In a subgroup of participants meeting at least one of
the criteria for the GI symptom complexes, respondents
with overlapping GI symptom complexes had signifi-
cantly higher odds of reporting poor self-rated health
and impaired functional capacity compared to respon-
dents with symptoms compatible with only one of the
symptom complexes, Table 4.
The experience of GI symptoms and overlap of symp-
toms was significantly associated with poor self-rated
health and impaired functional capacity for men and
women in both age groups.
Discussion
Summary of main findings
This study demonstrates that individuals experiencing
symptoms of either GERD, FD or IBS have significantly
higher odds of reporting poor self-rated health and im-
paired functional capacity compared to individuals not
experiencing these GI symptom complexes. This nega-
tive effect is amplified in individuals with symptoms of
two or all three of the conditions. The direction of the
Fig. 1 Study cohort
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association is similar for both men and women, irre-
spective of age.
Strengths and limitations
A random sample of the general population was pro-
vided by means of the CRS register. A response rate of
52.2% was received which is comparable to or higher
than other studies investigating self-reported symptoms
in a western general population [18, 19]. Slightly more
of the respondents were women, and slightly older than
the non-respondents [20].
In several studies, self-rated health is estimated by the
single question extracted from the Short Form 36, which
is a well validated and widely used instrument that has
been proved able to predict illness and death [21]. We
further added a question about functional capacity to de-
pict the consequences of affected self-rated health for
the individual’s everyday living.
Presence of symptoms and affected self-rated health/
functional capacity might affect the willingness to re-
spond to this questionnaire. The survey comprised, how-
ever, a wide range of symptoms, which might reduce the
risk that individuals with GI symptoms would be par-
ticularly interested in answering. Overestimation of
prevalence estimates cannot be eliminated if individuals
with no symptoms at all or with no affection of their
Table 4 Associations between poor self-rated health, impaired functional capacity and number of gastrointestinal symptom complexes
Total cohort Men Women
20–49 years ≥50 years 20–49 years ≥50 years
Odds ratios (95% confidence intervals) of poor self-rated health of the total cohort and stratified on age and gender
One symptom complex (either GERD, FD or IBS) 1 1 1 1 1
Two symptom complexes (FD + GERD, FD + IBS or
GERD + IBS)
1.87 (1.69–2.08) 1.62 (1.22–2.15) 1.76 (1.43–2.17) 2.52 (2.06–3.09) 1.59 (1.33–1.90)
Three symptom complexes (FD + GERD + IBS) 4.19 (3.59–4.88) 4.36 (2.00–6.33) 3.96 (2.84–5.53) 5.25 (3.87–7.13) 3.59 (2.78–4.63)
Odds ratios (95% confidence intervals) of impaired functional capacity of the total cohort and stratified on age and gender
One symptom complex (either GERD, FD or IBS) 1 1 1 1 1
Two symptom complexes (FD + GERD, FD + IBS or
GERD + IBS
1.93 (1.66–2.24) 2.01 (1.32–3.06) 1.57 (1.17–2.12) 2.47 (1.87–3.27) 1.77 (1.36–2.29)
Three symptom complexes (FD + GERD + IBS) 3.27 (2.68–3.97) 4.08 (2.48–6.72) 3.31 (2.23–4.93) 4.49 (3.11–6.49) 2.30 (1.61–3.27)
Poor self-related health is categorised as ‘Fair’ and ‘Poor’. Impaired functional capacity is categorised as ‘No’, and ‘Almost never’
GERD gastroesophageal reflux disease, FD functional dyspepsia, IBS irritable bowel syndrome
Table 3 Associations between poor self-rated health, impaired functional capacity and GI symptom complexes
Total cohort Men Women
20–49 years ≥50 years 20–49 years ≥50 years
Odds ratios (95% confidence intervals) of poor self-rated health of the total cohort and stratified on age and gender
Non-GERD/FD/IBS 1 1 1 1 1
Only GERD 3.33 (3.02–3.67) 4.19 (3.31–5.31) 2.84 (2.37–3.41) 3.46 (2.77–4.31) 3.28 (2.78–3.86)
Only IBS 2.85 (2.58–3.16) 3.95 (3.09–5.07) 3.50 (2.80–4.37) 2.59 (2.15–3.12) 2.67 (2.21–3.22)
Only FD 3.89 (3.42–4.44) 3.09 (2.08–4.58) 3.88 (3.06–4.92) 3.92 (2.98–5.17) 4.01 (3.22–4.99)
Two symptom complexes
(FD + GERD, FD + IBS or GERD + IBS)
6.07 (5.52–6.67) 6.32 (4.86–8.22) 5.72 (4.75–6.90) 7.69 (6.37–9.27) 5.08 (4.32–5.98)
Three symptom complexes (FD + GERD + IBS) 13.57 (11.71–15.73) 17.01 (11.88–24.36) 12.87 (9.34–17.72) 15.99 (11.90–21.50) 11.47 (8.99–14.63)
Odds ratios (95% confidence intervals) of impaired functional capacity of the total cohort and stratified on age and gender
Non-GERD/FD/IBS 1 1 1 1 1
Only GERD 2.88 (2.46–3.38) 3.34 (2.24–4.99) 2.75 (2.07–3.67) 3.49 (2.50–4.88) 2.42 (1.82–3.20)
Only IBS 2.65 (2.24–3.12) 3.48 (2.32–5.22) 3.15 (2.22–4.48) 2.57 (1.92–3.44) 2.27 (1.66–3.10)
Only FD 4.72 (3.93–5.67) 2.73 (1.41–5.26) 5.54 (4.05–7.59) 4.24 (2.84–6.34) 4.79 (3.53–6.50)
Two symptom complexes
(FD + GERD, FD + IBS or GERD + IBS)
6.05 (5.28–6.93) 6.62 (4.51–9.72) 5.46 (4.18–7.15) 7.67 (5.91–9.97) 5.01 (3.96–6.33)
Three symptom complexes (FD + GERD + IBS) 10.22 (8.49–12.31) 13.43 (8.41–21.46) 11.50 (7.89–16.77) 13.96 (9.80–19.89) 6.50 (4.65–9.10)
Poor self-related health is categorised as ‘Fair’ and ‘Poor’. Impaired functional capacity is categorised as ‘No’, and ‘Almost never’
GERD gastroesophageal reflux disease, FD functional dyspepsia, IBS irritable bowel syndrome
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self-rated health or functional capacity were less likely to
respond. The fact that the questionnaire was web-based
might have prevented some individuals from filling in
the questionnaire, especially the elderly. However, a
possible selection was sought minimised by offering in-
dividuals without internet access to complete the survey
by telephone interview.
Experience of symptoms within a period of 4 weeks
was chosen in order to have a sufficient number of
symptom experiences to obtain statistically precise es-
timates while assuming that people would be able to
recall symptoms fairly accurately [22, 23]. However, re-
call bias cannot entirely be eliminated. Some may mis-
remember symptom experiences to have occurred
within the last 4 weeks due to severity of the symptom.
Others who might have experienced mild or transient
symptoms or had not found the symptoms to be of any
concern may have forgotten about the symptom ex-
perience. Therefore, it is possible that individuals with
severe GI symptoms and secondary decreased self-
rated health/functional capacity might have a higher
recall of the symptoms compared to individuals with
GI symptoms not affecting their self-rated health/func-
tional capacity.
The symptom-based diagnostic criteria for IBS and FD
were based on the Rome III criteria, which have been
the accepted gold-standard for diagnosing FGIDs since
2006 [2]. During 2016 Rome IV diagnostic guidelines
were published [24] with minor alterations made to the
criteria for individual FGIDs. Sood and Ford emphasise
in a newly published paper [25], that the most substan-
tial change in the Rome IV is the recognition that a con-
siderable overlap exists between some of the FGIDs and
that they should be considered as part of a spectrum,
rather than discrete disorders. This is accordance with
the findings in the present paper. The alterations
should however be kept in mind when comparing fu-
ture studies.
Another limitation to keep in mind is the fact that we
do not have information about the respondents’ comor-
bidity. Especially among the elderly, it is possible that
decreased self-rated health and impaired functional
capacity are due to other illnesses and not merely attrib-
utable to the GI symptoms. However, the ORs for poor
self-rated health and impaired functional capacity in-
creased comparably with the number of symptoms for
respondents over and under 50 years of age. Neverthe-
less, using generic single item questions to measure gen-
eral self-rated health and functional capacity prevents us
from determining the GI symptoms that are the cause of
poor self-rated health and impaired functional capacity.
In this study, we can merely assess the associations
between GI symptoms experience and poor self-rated
health and impaired functional capacity.
Comparison to existing literature
It has previously been demonstrated that GERD, FD and
IBS decrease quality of life significantly [4–6]. One of
the studies also demonstrated that overlapping symp-
toms affect bodily pain and general health evaluation [6].
However, that also functional capacity is affected by GI
symptoms is new knowledge, and the amplification of
the negative effect on both self-rated health and func-
tional capacity in individuals with overlap of symptoms
of GERD, FD and IBS gives new insight into the conse-
quences of experiencing multiple GI symptoms.
Associations between functional disorders and anxiety
and depression are previously described [26], and an in-
creasing number of studies suggest that persistent and
multiple symptoms may lead to severe disability and
poor outcome [27]. Patient-reported outcomes (PROs)
are increasingly used to improve patient care as a sup-
plement to clinical information [28, 29]. PROs may aid
in the early identification of individuals at risk of poor
outcome and, with an enhanced focus on the individuals
instead of diagnoses, they might prevent harm from un-
necessary investigations and treatments inflicted by the
healthcare system.
Implications
Our findings suggest that the experience of multiple GI
symptoms is associated with poor self-rated health and
impaired functional capacity. Though the symptoms ori-
gin from the same organ system and hence might be per-
ceived by the patient as one illness, the negative impact of
experiencing symptoms compatible with two or all three
symptom complexes, GERD, FD and/or IBS should not be
underestimated. As a clinician it is important to consider
that symptoms of GERD, FD and/or IBS have a substantial
negative impact on the patients’ self-rated health and func-
tional capacity, and furthermore to acknowledge the amp-
lifying effect of overlapping symptoms.
Conclusion
In conclusion this study demonstrates that individuals
experiencing symptoms of either GERD, FD or IBS re-
port significantly low self-rated health as well as im-
paired functional capacity. This negative effect is
amplified in individuals of both gender and all ages ex-
periencing overlapping symptoms of GERD, FD and IBS.
Additional file
Additional file 1: The Danish Symptom Cohort – a survey about health,
symptoms and healthcare-seeking. The questionnaire was not available in
hard copy, but for illustrative purposes it has been reproduced in this
file. The file contains only items developed for use in this study. The
web-based questionnaire contains several leaps based on the answers
provided by the respondent (marked with explanatory captions in italic).
(DOCX 44 kb)
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